Skip to Main Content

Author Details

Megan Munsie
Stem Cell Ethics & Policy Group
1997
50
19
PMIDPaper TitleJournal TitlePublished Year
37348929Ethical analysis of the first porcine cardiac xenotransplantation.J Med Ethics2024
36736324Critical considerations for public engagement in stem cell-related research.Stem Cell Reports2023
37624740How Great a Risk Do You Take? A Qualitative Study Exploring Attitudes of Individuals with Friedreich Ataxia Toward Gene Therapy.Hum Gene Ther2023
37517865International Society for Cell & Gene Therapy Position Paper: Key considerations to support evidence-based cell and gene therapies and oppose marketing of unproven products.Cytotherapy2023
37471121Participatory Design and Evaluation of the "Stem Cells Australia" Website for Delivering Complex Health Knowledge: Mixed Methods Study.J Med Internet Res2023
34596479Developing a Reflexive, Anticipatory, and Deliberative Approach to Unanticipated Discoveries: Ethical Lessons from iBlastoids.Am J Bioeth2022
31081381From the margins to mainstream: How providers of autologous 'stem cell treatments' legitimise their practice in Australia.Health (London)2021
33563545Academic physician specialists' views toward the unproven stem cell intervention industry: areas of common ground and divergence.Cytotherapy2021
34454715Academic Physician Specialists' Approaches to Counseling Patients Interested in Unproven Stem Cell and Regenerative Therapies-A Qualitative Analysis.Mayo Clin Proc2021
34653406Ethical issues and public communication in the development of cell-based treatments for COVID-19: Lessons from the pandemic.Stem Cell Reports2021
33952390Regulating autologous stem cell interventions in Australia: updated review of the direct-to-consumer advertising restrictions.Aust Health Rev2021
34048692ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update.Stem Cell Reports2021
32228372Australian regulation of autologous human cell and tissue products: implications for commercial stem cell clinics.Regen Med2020
31951813Toward Guidelines for Research on Human Embryo Models Formed from Stem Cells.Stem Cell Reports2020
32009513The direct-to-consumer market for stem cell-based interventions in Australia: exploring the experiences of patients.Regen Med2020
32406622Unconventional Practice, "Innovative" Interventions and the National Law.J Law Med2020
30782021The politics of evidence in online illness narratives: An analysis of crowdfunding for purported stem cell treatments.Health (London)2019
31960784Contact us for more information: an analysis of public enquiries about stem cells.Regen Med2019
31599982Navigating the cartographies of trust: how patients and carers establish the credibility of online treatment claims.Sociol Health Illn2019
31045440Citizens' use of digital media to connect with health care: Socio-ethical and regulatory implications.Health (London)2019
30542177Debate ethics of embryo models from stem cells.Nature2018
30029023The current state of stem cell therapy for ocular disease.Exp Eye Res2018
30131270A roundtable on responsible innovation with autologous stem cells in Australia, Japan and Singapore.Cytotherapy2018
29800628Ethical issues in genetic modification and why application matters.Curr Opin Genet Dev2018
29930112Emerging stem cell ethics.Science2018
28679655Marketing of unproven stem cell-based interventions: A call to action.Sci Transl Med2017
28356490The deadly business of an unregulated global stem cell industry.J Med Ethics2017
28292838Ethical issues in human organoid and gastruloid research.Development2017
29125016Open for business: a comparative study of websites selling autologous stem cells in Australia and Japan.Regen Med2017
28976812The European General Data Protection Regulation: challenges and considerations for iPSC researchers and biobanks.Regen Med2017
29115901'No one here's helping me, what do you do?': addressing patient need for support and advice about stem cell treatments.Regen Med2017
28867848Regulating the stem cell industry: needs and responsibilities.Bull World Health Organ2017
26942850An Interactive Multimedia Approach to Improving Informed Consent for Induced Pluripotent Stem Cell Research.Cell Stem Cell2016
27299783Participant understanding and recall of informed consent for induced pluripotent stem cell biobanking.Cell Tissue Bank2016
27185282Setting Global Standards for Stem Cell Research and Clinical Translation: The 2016 ISSCR Guidelines.Stem Cell Reports2016
25367895Between hope and evidence: how community advisors demarcate the boundary between legitimate and illegitimate stem cell treatments.Health (London)2015
26418764What if stem cells turn into embryos in a dish?Nat Methods2015
24266861Therapeutic journeys: the hopeful travails of stem cell tourists.Sociol Health Illn2014
25457959Regulatory loophole enables unproven autologous cell therapies to thrive in Australia.Stem Cells Dev2014
24949190Managing the potential and pitfalls during clinical translation of emerging stem cell therapies.Clin Transl Med2014
24857592A question of ethics: selling autologous stem cell therapies flaunts professional standards.Stem Cell Res2014
22676869Tempering hope with realism: induced pluripotent stem cells in regenerative medicine.Med J Aust2012
19058776Isolation and production of cells suitable for human therapy: challenges ahead.Cell Stem Cell2009
19041777New ISSCR guidelines underscore major principles for responsible translational stem cell research.Cell Stem Cell2008
16761723Transgenic systems in nuclear reprogramming.Methods Mol Biol2006
15610154Electrical and neurotransmitter activity of mature neurons derived from mouse embryonic stem cells by Sox-1 lineage selection and directed differentiation.Eur J Neurosci2004
12180428Transgenic strategy for demonstrating nuclear reprogramming in the mouse.Cloning Stem Cells2002
10985386Isolation of pluripotent embryonic stem cells from reprogrammed adult mouse somatic cell nuclei.Curr Biol2000
10612469Novel method for demonstrating nuclear contribution in mouse nuclear transfer.Reprod Fertil Dev1998
9110310Expression of stem cell factor in the postnatal rat testis.Mol Reprod Dev1997
  • 1 - 50 of 50

Recommended Authors

Maeghan Toews
University of Adelaide
Career Start Year 2014
Number of shared co-authors 6
Shelly Benjaminy
Weill Cornell Medical College.
Career Start Year 2013
Number of shared co-authors 7
Vincent Couture
Universite Laval
Career Start Year 2013
Number of shared co-authors 0
Robert Ranisch
University of Potsdam
Career Start Year 2012
Number of shared co-authors 2
Erika Kleiderman
Universite de Montreal.
Career Start Year 2012
Number of shared co-authors 13
David Shaw
Care and Public Health Research Institute, Maastricht University
Career Start Year 2011
Number of shared co-authors 0
Blake Murdoch
University of Alberta
Career Start Year 2011
Number of shared co-authors 5
Kalina Kamenova
Canadian Institute for Genomics and Society.
Career Start Year 2010
Number of shared co-authors 6
Alejandro De Los Angeles
Massachusetts Institute of Technology
Career Start Year 2008
Number of shared co-authors 4
Jennifer B McCormick
Penn State College of Medicine
Career Start Year 2006
Number of shared co-authors 9
Mary Devereaux
Research Ethics Program, 4University of California
Career Start Year 2005
Number of shared co-authors 0
Sarah E Ali-Khan
McGill University
Career Start Year 2003
Number of shared co-authors 4
Alan Regenberg
Johns Hopkins Berman Institute of Bioethics
Career Start Year 2002
Number of shared co-authors 7
Vardit Ravitsky (CM4AI)
The Hastings Center
Career Start Year 2002
Number of shared co-authors 11
Ana S Iltis
Department of Philosophy and Center for Bioethics, Wake Forest University
Career Start Year 2000
Number of shared co-authors 3
Ivan Glenn Cohen
Petrie-Flom Center for Health Law Policy, Harvard University
Career Start Year 2000
Number of shared co-authors 10
Steven Joffe
Medical Ethics and Health Policy, University of Pennsylvania
Career Start Year 1999
Number of shared co-authors 6
Geoffrey Lomax
California Institute for Regenerative Medicine
Career Start Year 1999
Number of shared co-authors 12
David Magnus
Stanford Center for Biomedical Ethics, Stanford University
Career Start Year 1998
Number of shared co-authors 5
Carolyn Riley Chapman
Center for Human Genetics and Genomics, NYU Grossman School of Medicine
Career Start Year 1997
Number of shared co-authors 2
Nikolajs Zeps
Queensland University of Technology
Career Start Year 1996
Number of shared co-authors 4
Karen J Maschke
a nonprofit bioethics research institute
Career Start Year 1993
Number of shared co-authors 3
Don Chalmers
University of Tasmania
Career Start Year 1993
Number of shared co-authors 9
Michael McDonald
University of Central Florida
Career Start Year 1992
Number of shared co-authors 9
Henry T Greely
The Center for Law and the Biosciences, Stanford University
Career Start Year 1989
Number of shared co-authors 19
Eric M Meslin
Dalla Lana School of Public Health, University of Toronto
Career Start Year 1987
Number of shared co-authors 13
Fran??oise Baylis
Dalhousie University
Career Start Year 1987
Number of shared co-authors 6
Mildred K Cho
Center for Biomedical Ethics, Stanford University School of Medicine
Career Start Year 1985
Number of shared co-authors 9
Susan M Wolf
Law School and Medical School, University of Minnesota
Career Start Year 1984
Number of shared co-authors 3
Arthur L Caplan
Division of Medical Ethics, New York University Grossman School of Medicine
Career Start Year 1976
Number of shared co-authors 6

Collaborators

Insoo Hyun
Center for Bioethics, Harvard Medical School
Co-authored papers 7
Jeremy Sugarman
Johns Hopkins University, Berman Institute of Bioethics
Co-authored papers 7
Douglas Sipp
RIKEN Center for Biosystems Dynamics Research
Co-authored papers 5
Leigh Turner
University of California irvine
Co-authored papers 4
Alex W Hewitt
Menzies Institute for Medical Research, University of Tasmania
Co-authored papers 3
Nicolas C Rivron
Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA)
Co-authored papers 3
George Q Daley
Boston Children's Hospital, Harvard Medical School
Co-authored papers 3
Janet Rossant
The Hospital for Sick Children
Co-authored papers 3
Mahendra S Rao
Institute of Stem Cells and Regenerative Medicine (inStem)
Co-authored papers 3
Heather M Rooke
Broad Institute of Harvard and MIT
Co-authored papers 3
Misao Fujita
Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University
Co-authored papers 2
Christopher McCabe
Queens University Belfast
Co-authored papers 2
Jianping Fu
College of life sciences, Jiangxi Normal university
Co-authored papers 2
Rosario Isasi
Miller School of Medicine, University of Miami
Co-authored papers 2
Eva K Fenwick
Singapore Eye Research Institute, Duke-NUS Medical School
Co-authored papers 2
Zubin Master
Biomedical Ethics Research Program & Center for Regenerative Medicine, Mayo Clinic
Co-authored papers 2
Jonathan Kimmelman
McGill University
Co-authored papers 2
Christopher Gyngell
University of Melbourne
Co-authored papers 2
Timothy Caulfield
Faculty of Law and School of Public Health, University of Alberta
Co-authored papers 2
Amander T Clark
Center for Reproductive Science, University of California los angeles
Co-authored papers 2
Hiromitsu Nakauchi
Advanced Research Institute, Tokyo Medical and Dental University
Co-authored papers 2
Kazuto Kato
Osaka University
Co-authored papers 2
Amy Zarzeczny
University of Regina
Co-authored papers 2
Roger A Barker
John Van Geest Center for Brain Repair, University of Cambridge
Co-authored papers 2
Jane Kaye
University of Oxford
Co-authored papers 2
Robin Lovell-Badge
The Francis Crick Institute
Co-authored papers 2
Patricia J Zettler
Moritz College of Law and Comprehensive Cancer Center, The Ohio State University
Co-authored papers 2
E Clayton
Harvard Medical School, Vanderbilt University, Yale University Yale Law School
Co-authored papers 1
Roger A Pedersen
Stanford University
Co-authored papers 1
Luigi Naldini
Vita-Salute San Raffaele University
Co-authored papers 1
Release 1.2